Personalized glenoid implants
In a shoulder arthroplasty with a severe glenoid defect, the remaining bone stock is often insufficient to fixate standard baseplates, and the defect can be too large or oblique for a bone graft.
Don't compromise the outcome of complex shoulder cases. Enhance predictability with personalized Glenius implants.
Get it right first time
Powerful 3D planning and optimized implant design lead to a 96% survival rate.1
More than a revision implant
Most patients present Wallace type 2 and 3 defects in primary and revision cases.
Maximize bone preservation
Adapt the implant to the patient instead of the other way around.
Easily collaborate with expert clinical engineers using an intuitive online 3D planner.
How Glenius makes personalization easy
Unique 3D analysis
Based on the segmented CT scan, our experienced clinical engineers implement statistic shape model technology to quantify the glenoid bone loss.
Access the latest articles supporting clinical evidence for the Glenius implant here.
Treatment of severe glenoid deficiencies in reverse shoulder arthroplasty: the Glenius Glenoid Reconstruction System experience
Debeer P, Berghs B, Pouliart N, Van den Bogaert G, Verhaegen F, Nijs S. 2019
Functional and Radiological Outcomes after Treatment with Custom-Made Glenoid Components in Revision Reverse Shoulder Arthroplasty
Ortmaier, R.; Wierer, G.; Gruber, M.S. J. Clin. Med. 2022
“Seeing the patient three weeks after surgery with no pain and already substantial active ROM made my day. I am so happy having the Glenius component as a treatment option in those cases requiring reversed shoulder arthroplasty with severe bone loss of the glenoid.”
— Dr. H. Van der Bracht, AZ Sint-Lucas, Gent, Belgium
Discover how others benefit from the personalized Glenius implant.
Learn about Glenius and get support
Learn how to get started and see how leading experts are using the Glenius solution. If you are already a user, our customer support can help you with all your questions.
Frequently asked questions
1 Based on post-marketing surveillance (PMS) in 2019
This content is intended for healthcare professionals only